Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 133rd ranked industry out of 145 stock market industries

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
AVIR	ATEA PHARMACEUTICALS INC	$246.10M	-38.40%	-35.90%	-45.29%	-48.10%	0.09	16.66	N/A	N/A	N/A
KOD	KODIAK SCIENCES INC	$1.26B	-246.20%	-78.40%	-123.74%	-76.50%	8.20	1.79	N/A	N/A	N/A
VANI	VIVANI MEDICAL INC	$98.49M	-293.60%	-79.50%	-142.87%	-80.80%	18.13	0.61	N/A	N/A	N/A
GTBP	GT BIOPHARMA INC	$7.02M	-1,161.90%	-203.50%	-303.27%	392.30%	0.44	3.27	N/A	N/A	N/A
DNTH	DIANTHUS THERAPEUTICS INC	$1.81B	-33.00%	-31.10%	-22.82%	-34.90%	0.06	17.35	100.00%	-4,104.80%	-4,104.78%
VIR	VIR BIOTECHNOLOGY INC	$930.75M	-50.80%	-40.60%	-52.89%	-55.50%	0.28	7.25	95.90%	-2,963.50%	-2,961.95%
HOTH	HOTH THERAPEUTICS INC	$18.15M	-133.70%	-123.40%	-147.77%	-3,822.00%	0.12	8.81	N/A	N/A	N/A
AVTX	AVALO THERAPEUTICS INC	$337.29M	-88.40%	-73.90%	-86.18%	-288.20%	0.37	14.28	54.70%	-52,019.80%	-52,575.52%
SLDB	SOLID BIOSCIENCES INC	$457.33M	-73.60%	-60.00%	-70.12%	-112.70%	0.26	6.74	N/A	N/A	N/A
CCCC	C4 THERAPEUTICS INC	$239.38M	-64.40%	-38.70%	-51.82%	-44.80%	0.72	5.76	100.00%	-395.50%	-395.08%
VERA	VERA THERAPEUTICS INC	$3.18B	-50.90%	-42.70%	-51.39%	-43.50%	0.30	12.21	N/A	N/A	N/A
PMVP	PMV PHARMACEUTICALS INC	$65.45M	-55.30%	-51.00%	-69.86%	-78.60%	0.11	10.77	N/A	N/A	N/A
YDES	YD BIOPHARMA LTD	$869.18M	N/A	-12.30%	-20.99%	401.50%	0.04	13.18	30.40%	-276.60%	-271.52%
ENGN	ENGENE HOLDINGS INC	$431.24M	-39.90%	-34.20%	-40.52%	-44.20%	0.22	10.34	N/A	N/A	N/A
IOVA	IOVANCE BIOTHERAPEUTICS INC	$873.33M	-55.20%	-43.10%	-51.12%	-96.30%	0.29	3.41	24.00%	-158.80%	-159.06%
SNTI	SENTI BIOSCIENCES INC	$34.44M	-197.70%	-63.10%	-117.03%	-75.10%	5.49	1.51	N/A	N/A	N/A
CDT	CDT EQUITY INC	$2.85M	-2,194.50%	-289.50%	-444.72%	-897.30%	1.00	1.66	N/A	N/A	N/A
ARTV	ARTIVA BIOTHERAPEUTICS INC	$81.00M	-50.00%	-44.00%	-57.49%	-52.80%	0.15	11.65	N/A	N/A	N/A
CDXS	CODEXIS INC	$150.84M	-121.40%	-47.40%	-53.78%	-37.00%	2.22	4.12	79.30%	-120.80%	-107.17%
HOWL	WEREWOLF THERAPEUTICS INC	$53.39M	-144.40%	-71.70%	-109.10%	-184.00%	1.69	3.87	N/A	N/A	N/A
NVCT	NUVECTIS PHARMA INC	$194.42M	-155.40%	-99.90%	-115.81%	284.60%	0.48	3.07	N/A	N/A	N/A
AARD	AARDVARK THERAPEUTICS INC	$314.19M	-54.90%	-37.90%	-39.82%	-58.70%	0.09	12.04	N/A	N/A	N/A
LIMN	LIMINATUS PHARMA INC	$22.98M	N/A	N/A	N/A	N/A	-1.82	0.42	N/A	N/A	N/A
PRME	PRIME MEDICINE INC	$740.09M	-163.50%	-61.20%	-56.38%	-72.20%	1.38	6.61	100.00%	-3,301.60%	-3,301.64%
QNRX	QUOIN PHARMACEUTICALS LTD	$15.12M	-334.40%	-125.20%	-2,088.80%	-453.90%	-6.29	1.04	N/A	N/A	N/A
TRAW	TRAWS PHARMA INC	$18.62M	-2,912.00%	518.00%	2,048.95%	-1,528.40%	1.74	1.22	100.00%	3,280.00%	3,280.04%
ATOS	ATOSSA THERAPEUTICS INC	$106.57M	-49.40%	-44.80%	-60.62%	5,857.40%	0.17	6.77	N/A	N/A	N/A
SRRK	SCHOLAR ROCK HOLDING CORP	$4.78B	-122.00%	-86.50%	-100.33%	-144.60%	0.68	6.31	N/A	N/A	N/A
GRI	GRI BIO INC	$1.73M	-498.70%	-260.00%	-556.15%	711.60%	1.40	1.70	N/A	N/A	N/A
SPRC	SCISPARC LTD	$983.67k	396.50%	155.80%	13,168.14%	557.40%	-6.68	0.55	42.30%	1,312.80%	1,434.74%
OTLK	OUTLOOK THERAPEUTICS INC	$87.95M	N/A	-199.10%	476.73%	-544.00%	-1.60	0.67	70.80%	-2,885.80%	-2,881.12%
SNGX	SOLIGENIX INC	$16.64M	-267.10%	-135.70%	-149.12%	441.10%	0.49	3.18	N/A	N/A	N/A
NRIX	NURIX THERAPEUTICS INC	$1.47B	-53.60%	-40.80%	-55.44%	-52.30%	0.40	5.35	100.00%	-292.50%	-291.58%
CBUS	CIBUS INC	$87.40M	-166.90%	-34.90%	-27.31%	-31.10%	5.52	1.28	100.00%	-3,133.90%	-2,228.78%
PHGE	BIOMX INC	$3.48M	-68.40%	-35.00%	-51.75%	-43.60%	1.50	1.70	N/A	N/A	N/A
CTXR	CITIUS PHARMACEUTICALS INC	$19.05M	-62.80%	-33.70%	-51.63%	-60.40%	0.92	0.48	N/A	N/A	N/A
ABP	ABPRO HOLDINGS INC	$15.94M	N/A	-697.20%	68.47%	66.90%	-1.07	0.07	N/A	N/A	N/A
RCKT	ROCKET PHARMACEUTICALS INC	$366.87M	-62.40%	-53.90%	-70.95%	-83.00%	0.17	7.30	N/A	N/A	N/A
CRVO	CERVOMED INC	$78.19M	-76.80%	-68.10%	-98.36%	-106.60%	0.18	6.66	100.00%	-415.40%	-415.36%
MGTX	MEIRAGTX HOLDINGS PLC	$717.98M	-1,065.50%	-76.50%	-427.19%	-93.50%	-5.67	0.22	41.00%	-615.30%	-569.48%
REPL	REPLIMUNE GROUP INC	$798.55M	-82.80%	-61.60%	-89.68%	-75.20%	0.48	6.31	N/A	N/A	N/A
VKTX	VIKING THERAPEUTICS INC	$4.19B	-29.30%	-28.40%	-33.28%	-31.20%	0.04	28.34	N/A	N/A	N/A
IMVT	IMMUNOVANT INC	$4.63B	-84.90%	-76.10%	-88.98%	8,805.10%	0.12	9.07	N/A	N/A	N/A
ACHV	ACHIEVE LIFE SCIENCES INC	$247.01M	-196.70%	-118.30%	-121.91%	-306.00%	0.55	5.14	N/A	N/A	N/A
MNMD	MIND MEDICINE (MINDMED) INC	$1.24B	-86.20%	-62.30%	-95.18%	-120.30%	0.81	3.30	N/A	N/A	N/A
CYBN	CYBIN INC	$153.86M	-51.80%	-44.00%	-59.24%	-307.40%	0.30	8.58	N/A	N/A	N/A
PCVX	VAXCYTE INC	$5.83B	-21.10%	-19.70%	-22.12%	-22.30%	0.10	8.83	N/A	N/A	N/A
MGNX	MACROGENICS INC	$88.56M	-98.30%	-30.30%	-31.21%	-50.60%	3.04	5.22	75.40%	-59.50%	-55.34%
TIL	INSTIL BIO INC	$73.52M	-53.00%	-31.80%	-32.91%	-22.50%	0.76	34.45	N/A	N/A	N/A
SMMT	SUMMIT THERAPEUTICS INC	$13.08B	-311.20%	-262.40%	-463.89%	-997.70%	0.36	3.80	N/A	N/A	N/A
CRBP	CORBUS PHARMACEUTICALS HOLDINGS INC	$170.26M	-57.10%	-50.90%	-73.02%	-67.30%	0.19	6.31	N/A	N/A	N/A
ABSI	ABSCI CORP	$547.35M	-60.20%	-50.90%	-52.98%	-103.30%	0.17	5.89	100.00%	-4,071.20%	-4,051.97%
CABA	CABALETTA BIO INC	$227.19M	-107.10%	-82.90%	-108.54%	-298.40%	0.36	3.60	N/A	N/A	N/A
AUTL	AUTOLUS THERAPEUTICS PLC	$428.49M	-63.80%	-30.90%	-40.97%	-28.80%	1.49	6.19	-61.20%	-439.70%	-463.91%
BCTX	BRIACELL THERAPEUTICS CORP	$17.97M	-277.90%	-190.40%	-299.07%	-911.50%	0.40	3.42	N/A	N/A	N/A
AVBP	ARRIVENT BIOPHARMA INC	$1.01B	-59.70%	-55.70%	-49.64%	-90.90%	0.07	14.90	N/A	N/A	N/A
ONCY	ONCOLYTICS BIOTECH INC	$102.91M	-755.20%	-188.30%	-478.42%	2,290.60%	129.93	1.84	N/A	N/A	N/A
DWTX	DOGWOOD THERAPEUTICS INC	$15.64M	-1,440.60%	-42.10%	-42.34%	-1,187.90%	2.01	4.49	N/A	N/A	N/A
IMA	IMAGENEBIO INC	$72.68M	-36.90%	-33.00%	-30.17%	-58.90%	0.15	13.24	N/A	N/A	N/A
WHWK	WHITEHAWK THERAPEUTICS INC	$109.34M	-10.40%	-9.60%	-9.94%	-37.60%	0.06	16.76	89.20%	-108.60%	-108.58%
CLDX	CELLDEX THERAPEUTICS INC	$1.83B	-33.20%	-31.30%	-37.30%	-35.60%	0.08	13.01	100.00%	-8,635.80%	-8,635.85%
OBIO	ORCHESTRA BIOMED HOLDINGS INC	$254.66M	-320.10%	-106.20%	-88.59%	-154.00%	1.40	4.73	93.00%	-2,665.00%	-2,645.49%
MAIA	MAIA BIOTECHNOLOGY INC	$50.36M	-715.10%	-199.20%	-1,249.70%	434.20%	281.75	1.18	N/A	N/A	N/A
VOR	VOR BIOPHARMA INC	$130.24M	N/A	-1,545.90%	-1,556.28%	-10,196.70%	-1.08	9.16	N/A	N/A	N/A
ETHZ	ETHZILLA CORP	$169.37M	-199.50%	-89.30%	-23.60%	-96.60%	1.27	10.07	100.00%	-5,671.90%	-5,476.00%
KAPA	KAIROS PHARMA LTD	$14.99M	-79.20%	-71.20%	-66.05%	-177.20%	0.05	16.56	N/A	N/A	N/A
TECX	TECTONIC THERAPEUTIC INC	$369.83M	-27.10%	-25.90%	-24.75%	9,383.70%	0.04	29.15	N/A	N/A	N/A
JSPR	JASPER THERAPEUTICS INC	$49.53M	-261.90%	-150.80%	-249.87%	1,140.10%	3.97	2.59	N/A	N/A	N/A
QSI	QUANTUM-SI INC	$277.98M	-50.90%	-45.20%	-49.07%	-54.50%	0.11	10.75	51.70%	-3,678.00%	-3,675.98%
PMN	PROMIS NEUROSCIENCES INC	$19.35M	-336.90%	-184.40%	-316.68%	1,845.00%	1.34	1.76	N/A	N/A	N/A
CING	CINGULATE INC	$30.00M	-394.50%	-172.00%	-475.88%	-694.30%	2.03	1.26	N/A	N/A	N/A
MBRX	MOLECULIN BIOTECH INC	$10.14M	N/A	-207.10%	-281.90%	1,061.90%	-1.76	1.39	N/A	N/A	N/A
LRMR	LARIMAR THERAPEUTICS INC	$346.64M	-91.80%	-74.60%	-92.80%	-119.70%	0.35	4.06	N/A	N/A	N/A
SPRY	ARS PHARMACEUTICALS INC	$1.01B	-38.80%	-23.50%	-24.77%	-23.50%	1.53	6.66	89.40%	-56.10%	-55.86%
OSTX	OS THERAPIES INC	$63.74M	N/A	-278.90%	-380.14%	550.60%	1.17	0.56	N/A	N/A	N/A
DNA	GINKGO BIOWORKS HOLDINGS INC	$565.91M	-53.60%	-26.70%	-31.66%	-27.60%	1.12	4.39	72.70%	-188.00%	-188.24%
ATYR	ATYR PHARMA INC	$75.94M	-100.10%	-74.70%	-82.58%	-88.10%	0.33	5.93	100.00%	-39,537.90%	-39,537.89%
ARTL	ARTELO BIOSCIENCES INC	$3.94M	-3,398.90%	-296.80%	2,075.55%	435.50%	-7.74	0.38	N/A	N/A	N/A
RXRX	RECURSION PHARMACEUTICALS INC	$2.25B	-72.70%	-52.50%	-57.51%	-311.80%	0.34	4.60	-59.00%	-1,637.80%	-1,638.15%
MLTX	MOONLAKE IMMUNOTHERAPEUTICS	$949.97M	-57.10%	-45.90%	-56.85%	-96.50%	0.43	8.50	N/A	N/A	N/A
BBOT	BRIDGEBIO ONCOLOGY THERAPEUTICS INC	$1.01B	-293.90%	-59.90%	-34.20%	-117.30%	0.09	13.33	N/A	N/A	N/A
SKYE	SKYE BIOSCIENCE INC	$34.94M	-100.50%	-88.70%	-155.57%	-417.30%	0.26	4.77	N/A	N/A	N/A
LGVN	LONGEVERON INC	$12.99M	-138.40%	-108.50%	-201.01%	-1,125.00%	0.56	2.09	74.90%	-1,485.10%	-1,485.11%
ICCC	IMMUCELL CORP	$56.17M	8.00%	5.10%	5.60%	4.60%	0.54	4.21	40.90%	8.40%	8.42%
BLRX	BIOLINERX LTD	$17.28M	-16.10%	-7.20%	9.58%	53.60%	1.04	2.09	50.70%	-23.40%	19.65%
APM	APTORUM GROUP LTD	$9.29M	-9.00%	-11.50%	-11.35%	-10.60%	0.19	2.98	N/A	N/A	N/A
GDTC	CYTOMED THERAPEUTICS LTD	$19.16M	-42.40%	-38.10%	-47.70%	-75.20%	0.16	5.81	84.10%	-1,629.20%	-1,619.98%
GLMD	GALMED PHARMACEUTICALS LTD	$5.75M	-47.80%	-42.60%	-49.15%	-68.70%	0.13	7.98	N/A	N/A	N/A
GRCE	GRACE THERAPEUTICS INC	$46.77M	-12.80%	-11.60%	-14.45%	758.10%	0.06	13.89	N/A	N/A	N/A
APRE	APREA THERAPEUTICS INC	$5.90M	-88.10%	-68.80%	-118.96%	597.10%	0.31	5.20	100.00%	-2,670.60%	-2,836.07%
ANTX	AN2 THERAPEUTICS INC	$32.88M	-47.80%	-43.00%	-56.29%	-65.70%	0.11	9.33	N/A	N/A	N/A
ALZN	ALZAMEND NEURO INC	$8.25M	-151.10%	-128.20%	-134.30%	9,732.00%	0.16	6.58	N/A	N/A	N/A
AIM	AIM IMMUNOTECH INC	$3.91M	N/A	-257.40%	-1,047.35%	462.40%	-1.90	0.64	15.20%	-14,062.50%	-13,568.75%
ADIL	ADIAL PHARMACEUTICALS INC	$7.10M	-197.70%	-153.70%	-178.73%	8,956.20%	0.26	4.34	N/A	N/A	N/A
SILO	SILO PHARMA INC	$5.78M	-107.00%	-77.10%	-89.35%	-366.70%	0.28	8.70	65.20%	-7,041.10%	-7,034.36%
ACET	ADICET BIO INC	$76.47M	-77.90%	-64.30%	-94.62%	-84.00%	0.29	5.62	N/A	N/A	N/A
AAPG	ASCENTAGE PHARMA GROUP INTERNATIONAL	$2.65B	-161.90%	-37.80%	-60.39%	-50.70%	3.56	1.54	90.90%	-296.80%	-277.82%
RPTX	REPARE THERAPEUTICS INC	$91.99M	-57.60%	-50.00%	-62.05%	-145.40%	0.10	10.71	100.00%	-608.30%	-601.83%
RLYB	RALLYBIO CORP	$30.92M	-25.20%	-23.20%	-22.44%	-36.50%	0.07	14.74	100.00%	-2,102.40%	-2,102.37%
PULM	PULMATRIX INC	$16.73M	-94.10%	-85.40%	-131.42%	1,844.30%	0.05	19.97	100.00%	-207,333.30%	-207,333.33%

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Dec 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Beone Medicines (NASDAQ:ONC)

Beone Medicines (NASDAQ:ONC) is the #1 top biotech stock out of 617 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Beone Medicines (NASDAQ:ONC) is: Value: B, Growth: A, Momentum: B, Sentiment: A, Safety: C, Financials: C, and AI: B.

Beone Medicines (NASDAQ:ONC) has a Due Diligence Score of 53, which is 30 points higher than the biotech industry average of 23.

ONC passed 18 out of 33 due diligence checks and has strong fundamentals. Beone Medicines has seen its stock return 76.99% over the past year, overperforming other biotech stocks by 122 percentage points.

Beone Medicines has an average 1 year price target of $390.88, an upside of 22.51% from Beone Medicines's current stock price of $319.06.

Beone Medicines stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 8 analysts covering Beone Medicines, 75% have issued a Strong Buy rating, 25% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Aurinia Pharmaceuticals (NASDAQ:AUPH)

Aurinia Pharmaceuticals (NASDAQ:AUPH) is the #2 top biotech stock out of 617 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Aurinia Pharmaceuticals (NASDAQ:AUPH) is: Value: B, Growth: C, Momentum: B, Sentiment: B, Safety: C, Financials: A, and AI: B.

Aurinia Pharmaceuticals (NASDAQ:AUPH) has a Due Diligence Score of 46, which is 23 points higher than the biotech industry average of 23.

AUPH passed 15 out of 33 due diligence checks and has strong fundamentals. Aurinia Pharmaceuticals has seen its stock return 63.57% over the past year, overperforming other biotech stocks by 109 percentage points.

Aurinia Pharmaceuticals has an average 1 year price target of $17.25, an upside of 8.83% from Aurinia Pharmaceuticals's current stock price of $15.85.

Aurinia Pharmaceuticals stock has a consensus Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Aurinia Pharmaceuticals, 25% have issued a Strong Buy rating, 25% have issued a Buy, 50% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Innoviva (NASDAQ:INVA)

Innoviva (NASDAQ:INVA) is the #3 top biotech stock out of 617 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Innoviva (NASDAQ:INVA) is: Value: A, Growth: C, Momentum: C, Sentiment: B, Safety: C, Financials: A, and AI: C.

Innoviva (NASDAQ:INVA) has a Due Diligence Score of 45, which is 22 points higher than the biotech industry average of 23.

INVA passed 14 out of 33 due diligence checks and has strong fundamentals. Innoviva has seen its stock return 11.21% over the past year, overperforming other biotech stocks by 56 percentage points.

Innoviva has an average 1 year price target of $32.00, an upside of 55.11% from Innoviva's current stock price of $20.63.

Innoviva stock has a consensus Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Innoviva, 25% have issued a Strong Buy rating, 50% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 25% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 4 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 12.13%, which is 9 percentage points higher than the biotech industry average of 2.94%.

Dominari Holdings's dividend payout ratio of 8.4% indicates that its high dividend yield is sustainable for the long-term.

2. Royalty Pharma (NASDAQ:RPRX)

Royalty Pharma (NASDAQ:RPRX) has an annual dividend yield of 2.29%, which is -1 percentage points lower than the biotech industry average of 2.94%. Royalty Pharma's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Royalty Pharma's dividend has shown consistent growth over the last 10 years.

Royalty Pharma's dividend payout ratio of 49.4% indicates that its dividend yield is sustainable for the long-term.

3. Bio Techne (NASDAQ:TECH)

Bio Techne (NASDAQ:TECH) has an annual dividend yield of 0.55%, which is -2 percentage points lower than the biotech industry average of 2.94%. Bio Techne's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Bio Techne's dividend has not shown consistent growth over the last 10 years.

Bio Techne's dividend payout ratio of 64% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks down?

Biotech stocks were down -0.42% in the last day, and up 0.28% over the last week. Sonnet Biotherapeutics Holdings was the among the top losers in the biotechnology industry, dropping -59.35% yesterday.

Sonnet BioTherapeutics Holdings shares are trading lower after the company announced its stockholders approved a business combination with Hyperliquid Strategies and Rorschach I.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 57, which is 42 points higher than the biotech industry average of 15. It passed 4 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has gained 27.15% in the past year. It has overperformed other stocks in the biotech industry by 72 percentage points.

2. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Puma Biotechnology has a valuation score of 43, which is 28 points higher than the biotech industry average of 15. It passed 3 out of 7 valuation due diligence checks.

Puma Biotechnology's stock has gained 100.68% in the past year. It has overperformed other stocks in the biotech industry by 146 percentage points.

3. Innoviva (NASDAQ:INVA)

Innoviva (NASDAQ:INVA) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Innoviva has a valuation score of 43, which is 28 points higher than the biotech industry average of 15. It passed 3 out of 7 valuation due diligence checks.

Innoviva's stock has gained 11.21% in the past year. It has overperformed other stocks in the biotech industry by 56 percentage points.

Are biotech stocks a good buy now?

59.96% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 47.99% over the next year.

3.31% of biotech stocks have a Zen Rating of A (Strong Buy), 6.42% of biotech stocks are rated B (Buy), 44.93% are rated C (Hold), 32.3% are rated D (Sell), and 13.04% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 155.66x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Beone Medicines (NASDAQ:ONC)

2. Aurinia Pharmaceuticals (NASDAQ:AUPH)

3. Innoviva (NASDAQ:INVA)

1. Dominari Holdings (NASDAQ:DOMH)

2. Royalty Pharma (NASDAQ:RPRX)

3. Bio Techne (NASDAQ:TECH)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Puma Biotechnology (NASDAQ:PBYI)

3. Innoviva (NASDAQ:INVA)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBiotechnologyBest Biotech Stocks to Buy Now (2025)Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Beone Medicines (NASDAQ:ONC)

2. Aurinia Pharmaceuticals (NASDAQ:AUPH)

3. Innoviva (NASDAQ:INVA)

1. Dominari Holdings (NASDAQ:DOMH)

2. Royalty Pharma (NASDAQ:RPRX)

3. Bio Techne (NASDAQ:TECH)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Puma Biotechnology (NASDAQ:PBYI)

3. Innoviva (NASDAQ:INVA)

Company

Stock Tools

Stock Ideas

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.